team_image
Olav Flaten, MD PhD, Chairman  

Many years in international biotech and pharma industry, with longstanding executive experience from different countries. Excellent network in Scandinavia and other European countries. Member of numerous committees and experienced board member, also of public listed company. High business acumen and knowledge of international business development. Experienced consultant in commercialization, partnering and business development for companies engaged in biotechnology, medical technology, pharmaceuticals and nutraceuticals.

team_image
François Curtin MD, Member of the Board  

Graduated from Geneva Medical School and has further qualifications from the London School of Hygiene and Tropical Medicine and the Warwick University. After working several years in academic research, Francois joined Serono and then Merck-Serono, holding different management positions in clinical and business development. He is currently Chief Operation Officer at Geneuro, a Swiss biotech. He has academic appointments at the University of Geneva, teaching pharmacology and biostatistics.

team_image
Antonio Guglietta MD, PhD, Member of the Board  

Over 25 years experience in science and pharmaceutical industry at organizations located in Italy, US and Spain (U. of Rome, Natl. Inst. Env. Health Sci., GSK, Parke-Davis, Grupo Ferrer). Director of R&D at Grupo Ferrer in Barcelona, Spain from 2000 to 2012. Hands-on experience in drug discovery and development with proven track record of achievements. Several drugs developed all the way to the market and extensive international business experience.

team_image
Ferdinando Nicoletti MD, Member of the Board  

Full Professor of Pathology and Immunology at the University of Catania (Italy) and CSO of Onconox. More than 250 papers in peer reviewed journals and inventor of 9 patents. Serves in the Editorial Boards of several international journals :Recent Fundraised more than 4 million euros at the University of Catania through national and international research grants. Co-founder of GaNiAl Immunotherapeutic Inc (USA) and Onconox AS (Denmark).